Logo image
Sign in
Comments on: "Docetaxel Plus Trabectedin Appears Active in Recurrent Or Persistent Ovarian and Primary Peritoneal Cancer After Up to Three Prior Regimens" (Monk BJ, Sill MW, Hanjani P, Edwards R, Rotmensch J, De Geest K, Et Al. Gynecol Oncol. 2011 Mar;120(3):459-63)
Journal article

Comments on: "Docetaxel Plus Trabectedin Appears Active in Recurrent Or Persistent Ovarian and Primary Peritoneal Cancer After Up to Three Prior Regimens" (Monk BJ, Sill MW, Hanjani P, Edwards R, Rotmensch J, De Geest K, Et Al. Gynecol Oncol. 2011 Mar;120(3):459-63)

M. W. Sill and Bradley J. Monk
Gynecologic Oncology, Vol.122(2), pp.462-463
08/2011

Metrics

5 Record Views

Details